A.AhmadI.AlarfajA
In the 1980s, experts indicated that an RDA for carnitine was not necessary because the human body can make its own
Challenges: The key challenge for Sanofi is competition from more established and better marketed GLP-1 drugs, particularly those from Novo Nordisk and Eli Lilly
For these unmet needs, development of biopharmaceuticals using in vivo mechanisms was initiated and soon became the core technology of drug development (Gavrilescu & Chisti, Citation2005)
Particularly, the human hepatic cell line HepG2 transfection with miR-370 upregulates the expression of miR-122
385,387 PF1801 displays its anti-inflammatory effects by lowering levels of inflammatory mediators such as TNF, IL-6, and HMGB1, and enhances the cells antioxidant capability by upregulating molecules like Nfe2l2, Hmox1, Gclm, and Nqo1, which further improves cellular defense against oxidative stress and protects them from further damage